Filing Details
- Accession Number:
- 0001179110-17-008220
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-05-30 19:46:19
- Reporting Period:
- 2017-05-16
- Filing Date:
- 2017-05-30
- Accepted Time:
- 2017-05-30 19:46:19
- Original Submission Date:
- 2017-05-18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1251769 | Apollo Endosurgery Inc. | APEN | Biological Products, (No Disgnostic Substances) (2836) | 161630142 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1689402 | Jr. D. William Mcclellan | 274 Buck Bend Georgetown TX 78628 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-16 | 300 | $6.19 | 300 | No | 4 | P | Indirect | William D McClellan & Jan McClellan CO-TTEE McClellan Living Trust U/A |
Common Stock | Acquisiton | 2017-05-17 | 1,700 | $6.35 | 2,000 | No | 4 | P | Indirect | William D McClellan & Jan McClellan CO-TTEE McClellan Living Trust U/A |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | William D McClellan & Jan McClellan CO-TTEE McClellan Living Trust U/A |
No | 4 | P | Indirect | William D McClellan & Jan McClellan CO-TTEE McClellan Living Trust U/A |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.19 to $6.20, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.12 to $6.45, inclusive.